Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-17-006319
Filing Date
2017-07-26
Accepted
2017-07-26 08:21:31
Documents
14

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2470921
2 filename2.htm EX-99 1981
3 GRAPHIC g407559g10q36.jpg GRAPHIC 88982
4 GRAPHIC g407559g29y33.jpg GRAPHIC 165587
5 GRAPHIC g407559g30i60.jpg GRAPHIC 104714
6 GRAPHIC g407559g37k67.jpg GRAPHIC 122591
7 GRAPHIC g407559g38h83.jpg GRAPHIC 44007
8 GRAPHIC g407559g40w11.jpg GRAPHIC 107501
9 GRAPHIC g407559g52v95.jpg GRAPHIC 55697
10 GRAPHIC g407559g55s41.jpg GRAPHIC 162989
11 GRAPHIC g407559g64o58.jpg GRAPHIC 139970
12 GRAPHIC g407559g66n68.jpg GRAPHIC 44409
13 GRAPHIC g407559g72k11.jpg GRAPHIC 36000
14 GRAPHIC g407559g89j19.jpg GRAPHIC 82797
  Complete submission text file 0000950123-17-006319.txt   4066023
Mailing Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052
Business Address TECHNOLOGIEPARK 21 ZWIJNAARDE GHENT C9 9052 003292620000
Ablynx NV (Filer) CIK: 0001617582 (see all company filings)

EIN.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01598 | Film No.: 17981701
SIC: 2836 Biological Products, (No Diagnostic Substances)